September 23, 2025 at 01:08AM FDA use of Real-World Evidence in Regulatory Decision Making

The studies presented in the accompanying tables exemplify instances in which the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) applied RWE in regulatory decision-making processes since 2011.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/d5XFNMs